These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7530356)

  • 21. [Critical ischemia in elderly patients. Evaluation of the effect of two different methods of Iloprost therapy on the efficacy, tolerance, modification of quality of life and self-sufficiency].
    Cappelli R; Bicchi M; Arrigucci S; Boschi S; Guerrini M; Forconi S
    Minerva Cardioangiol; 1999 Mar; 47(3):81-8. PubMed ID: 10389449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease.
    Gianetti J; De Caterina M; De Cristofaro T; Ungaro B; Guercio RD; De Caterina R
    Am Heart J; 2001 Oct; 142(4):733-9. PubMed ID: 11579367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of thrombinic activation indexes, in patients with lower limb critic ischaemia, before and after prostaglandin E1 therapy.
    Trifiletti A; Bartolone S; Scamardi R; Pizzoleo MA; Attinà A; Sottilotta G; Canobbio V; Soraci S; Barbera N
    Minerva Cardioangiol; 1999 Mar; 47(3):55-8. PubMed ID: 10389444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A new infusion method for a prostacyclin analogue].
    Pibiri L; Petruzzo P; Angius D; Ruiu G; Polo F; Rescigno A; Brotzu G
    Minerva Cardioangiol; 1997 Dec; 45(12):621-5. PubMed ID: 9577128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of iloprost on plasma asymmetric dimethylarginine and plasma and platelet serotonin in patients with peripheral arterial occlusive disease.
    Blardi P; de Lalla A; Pieragalli D; De Franco V; Meini S; Ceccatelli L; Auteri A
    Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):175-82. PubMed ID: 16939882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short- and long-term treatments with iloprost in diabetic patients with peripheral vascular disease: effects on the cardiovascular risk factor plasminogen activator inhibitor type-1.
    Cozzolino D; Coppola L; Masi S; Salvatore T; Sasso FC; De Lucia D; Gentile S; Torella R
    Eur J Clin Pharmacol; 1999 Sep; 55(7):491-7. PubMed ID: 10501817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibrinolytic enhancement with a prostaglandin analogue iloprost.
    Berridge DC; Lonsdale R; Jallihal S; Westby JC; Hopkinson BR; Makin GS
    Agents Actions Suppl; 1992; 37():258-64. PubMed ID: 1378686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV
    Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment with iloprost of critical ischemia of the lower limbs associated with cardiac insufficiency. Study of interaction with the pharmacokinetics of digoxin].
    Cabane J; Penin I; Bouslama K; Benchouieb A; Giral P; Picard O; Wattiaux MJ; Cheymol G; Souvignet G; Imbert JC
    Therapie; 1991; 46(3):235-40. PubMed ID: 1724327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcutaneous oxygen and carbon dioxide during treatment of critical limb ischemia with iloprost, a prostacyclin derivative.
    Melillo E; Iabichella L; Berchiolli R; Ferrari M; Catapano G; Dell'Omo G; Pedrinelli R
    Int J Microcirc Clin Exp; 1995; 15(2):60-4. PubMed ID: 8655253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.
    Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ
    Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood coagulation and fibrinolysis activation during sudden arterial occlusion of lower extremities--an association with ischemia and patient outcome.
    Peltonen S; Lassila R; Rossi P; Salenius JP; Lepäntalo M
    Thromb Haemost; 1995 Dec; 74(6):1442-6. PubMed ID: 8772217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia.
    Di Stefano R; Barsotti MC; Melillo E; Iorio M; Santoni T; Armani C; Dell'omodarme M; Ristori C; De Caterina R; Balbarini A
    Thromb Haemost; 2008 Nov; 100(5):871-7. PubMed ID: 18989532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six years' experience with prostaglandin I2 infusion in elective open repair of abdominal aortic aneurysm: a parallel group observational study in a tertiary referral vascular center.
    Beirne C; Hynes N; Sultan S
    Ann Vasc Surg; 2008 Nov; 22(6):750-5. PubMed ID: 18992665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
    Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
    Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
    Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
    Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of levosimendan and iloprost on lung injury induced by limb ischemia-reperfusion: a rabbit model.
    Yasa H; Yakut N; Emrecan B; Ergunes K; Ortac R; Karahan N; Ozbek C; Gurbuz A
    J Surg Res; 2008 Jun; 147(1):138-42. PubMed ID: 18222476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.